Department of Orthopaedics, Second Hospital of Shanxi Medical University, Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair, No. 382, Wuyi Road, Taiyuan, 030001, Shanxi, China.
School of Mechanical Engineering, Hangzhou Dianzi University, Hangzhou, 310018, China.
Sci Rep. 2024 Jun 8;14(1):13207. doi: 10.1038/s41598-024-63837-8.
Femoral head necrosis (FHN) is a serious complication after femoral neck fractures (FNF), often linked to sclerosis around screw paths. Our study aimed to uncover the proteomic and metabolomic underpinnings of FHN and sclerosis using integrated proteomics and metabolomics analyses. We identified differentially expressed proteins (DEPs) and metabolites (DEMs) among three groups: patients with FNF (Group A), sclerosis (Group B), and FHN (Group C). Using the Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichment analyses, we examined the roles of these proteins and metabolites. Our findings highlight the significant differences across the groups, with 218 DEPs and 44 DEMs identified between the sclerosis and FNF groups, 247 DEPs and 31 DEMs between the FHN and sclerosis groups, and a stark 682 DEPs and 94 DEMs between the FHN and FNF groups. Activities related to carbonate dehydratase and hydrolase were similar in the FHN and sclerosis groups, whereas extracellular region and lysosome were prevalent in the FHN and FNF groups. Our study also emphasized the involvement of the PI3K-Akt pathway in sclerosis and FHN. Moreover, the key metabolic pathways were implicated in glycerophospholipid metabolism and retrograde endocannabinoid signaling. Using western blotting, we confirmed the pivotal role of specific genes/proteins such as ITGB5, TNXB, CA II, and CA III in sclerosis and acid phosphatase 5 and cathepsin K in FHN. This comprehensive analyses elucidates the molecular mechanisms behind sclerosis and FHN and suggests potential biomarkers and therapeutic targets, paving the way for improved treatment strategies. Further validation of the findings is necessary to strengthen the robustness and reliability of the results.
股骨头坏死(FHN)是股骨颈骨折(FNF)后的严重并发症,常与螺钉路径周围的硬化有关。我们的研究旨在通过整合蛋白质组学和代谢组学分析,揭示 FHN 和硬化的蛋白质组学和代谢组学基础。我们在三组患者中鉴定了差异表达的蛋白(DEPs)和代谢物(DEMs):股骨颈骨折患者(A 组)、硬化患者(B 组)和股骨头坏死患者(C 组)。我们使用京都基因与基因组百科全书和基因本体论富集分析,研究了这些蛋白和代谢物的作用。我们的研究结果突出了各组之间的显著差异,在硬化与 FNF 组之间鉴定出 218 个 DEPs 和 44 个 DEMs,在 FHN 与硬化组之间鉴定出 247 个 DEPs 和 31 个 DEMs,在 FHN 与 FNF 组之间鉴定出 682 个 DEPs 和 94 个 DEMs。FHN 和硬化组中碳酸脱水酶和水解酶的活性相似,而 FHN 和 FNF 组中细胞外区域和溶酶体则较为普遍。我们的研究还强调了 PI3K-Akt 通路在硬化和 FHN 中的作用。此外,关键代谢途径与甘油磷脂代谢和逆行内源性大麻素信号有关。通过 Western blot 分析,我们证实了特定基因/蛋白(如 ITGB5、TNXB、CA II 和 CA III)在硬化中的关键作用以及酸性磷酸酶 5 和组织蛋白酶 K 在 FHN 中的关键作用。这些综合分析阐明了硬化和 FHN 背后的分子机制,并提出了潜在的生物标志物和治疗靶点,为改善治疗策略铺平了道路。需要进一步验证这些发现,以增强结果的稳健性和可靠性。